![Vincent Mutel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vincent Mutel
Directeur Général chez
Inflamalps SA
Profil
Vincent Mutel was the founder of Addex Therapeutics Ltd. founded in 2002, where the title held was Chief Executive Officer from 2002 to 2010.
Dr. Mutel is the founder of Inflamalps SA founded in 2012, holding the title Chairman & Chief Executive Officer.
Dr. Mutel is the founder of GAOMA Therapeutics SAS founded in 2019, holding the title Chief Executive Officer since 2019.
The current job is Director at Metys Pharmaceuticals AG.
Former jobs include Non-Executive Director at Lectus Therapeutics Ltd., Head-Pharmacology at F.
Hoffmann-La Roche Ltd., Principal at Basel - SpA, and Principal at CRI Worldwide LLC.
Education includes a doctorate from the University of Paris Jussieu conferred in 1987.
Postes actifs de Vincent Mutel
| Sociétés | Poste | Début |
|---|---|---|
Inflamalps SA
 Inflamalps SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops topical treatments for inflammation-mediated diseases in ophthalmology and dermatology | Directeur Général | 01/08/2012 |
Metys Pharmaceuticals AG
 Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Vincent Mutel
| Sociétés | Poste | Fin |
|---|---|---|
CRI Worldwide LLC
 CRI Worldwide LLC Miscellaneous Commercial ServicesCommercial Services Provides inpatient and outpatient clinical research services | Corporate Officer/Principal | - |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Lectus Therapeutics Ltd.
 Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Directeur/Membre du Conseil | - |
Basel - SpA
 Basel - SpA MiscellaneousMiscellaneous Operates as a non-classified establishment | Corporate Officer/Principal | - |
| ADDEX THERAPEUTICS LTD | Fondateur | - |
Formation de Vincent Mutel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Basel - SpA
Basel - SpA MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Lectus Therapeutics Ltd.
Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Developed ion channel modulators and therapeutics | Health Technology |
Addex Therapeutics Ltd.
 Addex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs | Health Technology |
University of Paris Jussieu
 University of Paris Jussieu Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRI Worldwide LLC
CRI Worldwide LLC Miscellaneous Commercial ServicesCommercial Services Provides inpatient and outpatient clinical research services | Commercial Services |
Inflamalps SA
Inflamalps SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops topical treatments for inflammation-mediated diseases in ophthalmology and dermatology | Health Technology |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
